HS
Horan Securities Portfolio holdings
AUM
$284M
This Quarter Return
-8.74%
1 Year Return
+12.31%
3 Year Return
+50.18%
5 Year Return
–
10 Year Return
–
AUM
$85.7M
AUM Growth
+$85.7M
(-16%)
Cap. Flow
-$13.4M
Cap. Flow
% of AUM
-15.63%
Top 10 Holdings %
Top 10 Hldgs %
73.87%
Holding
240
New
22
Increased
41
Reduced
32
Closed
13
Top Buys
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
$725K |
| 2 |
iShares National Muni Bond ETF
MUB
|
$225K |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$205K |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
$185K |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
$139K |
Top Sells
| 1 |
iShares Core MSCI Total International Stock ETF
IXUS
|
$4.5M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$2.96M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$2.55M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
$1.28M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
$1.07M |
Sector Composition
| 1 | Consumer Staples | 3.36% |
| 2 | Technology | 0.75% |
| 3 | Industrials | 0.69% |
| 4 | Financials | 0.57% |
| 5 | Healthcare | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.4B
| – | – |
-49
| Closed | -$3K |
|
227
SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.45B
| – | – |
-38
| Closed | -$2K |
|
228
NVIDIA
NVDA
$4.15T
| $0 | ﹤0.01% |
80
| – | – |
|
229
PayPal
PYPL
$66.5B
| – | – |
-100
| Closed | -$8K |
|
230
SPDR S&P 600 Small Cap Growth ETF
SLYG
$3.51B
| – | – |
-35
| Closed | -$2K |
|
231
SPDR S&P 600 Small Cap Value ETF
SLYV
$4B
| – | – |
-20
| Closed | -$1K |
|
232
Sensient Technologies
SXT
$4.8B
| – | – |
-1,565
| Closed | -$101K |
|
233
Stock Yards Bancorp
SYBT
$2.34B
| $0 | ﹤0.01% |
7
| – | – |
|
234
Teva Pharmaceuticals
TEVA
$21.5B
| $0 | ﹤0.01% |
10
| – | – |
|
235
Western Digital
WDC
$29.8B
| – | – |
-132
| Closed | -$6K |
|
236
Weyerhaeuser
WY
$17.9B
| – | – |
-140
| Closed | -$4K |
|
237
SPDR S&P Health Care Equipment ETF
XHE
$151M
| – | – |
-25
| Closed | -$2K |
|
|
DNKN
238
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $0 | ﹤0.01% |
1
| – | – |
|
|
NVLN
239
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $0 | ﹤0.01% |
12
| – | – |
|
|
GCVRZ
240
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $0 | ﹤0.01% |
30
| – | – |
|